MatsukiyoCocokara & Co (3088) Stock Price

Market cap
¥1.03T
P/E ratio
17.5x
Operates drugstore and prescription pharmacy chains across Japan, offering pharmaceuticals, cosmetics, daily necessities, and healthcare services including nursing care.

Price and Volume

Market Cap

Subscribe to premium to access
Market Cap.

Check pricing

PER

Subscribe to premium to access
PER.

Check pricing

PBR

Business Overview

Matsukiyo Cocokara & Company operates retail businesses primarily consisting of drugstore and prescription pharmacy chain stores, as well as administrative support services. The company is composed of 30 entities in total, including 20 consolidated subsidiaries, 8 non-consolidated subsidiaries, and 1 affiliated company not accounted for using the equity method.

The Matsumoto Kiyoshi Group business operates chains of drugstores and prescription pharmacies. It also handles the opening and operation of prescription pharmacies, franchise business development, and product supply to franchisees.

The Cocokara Fine Group business operates drugstore and prescription pharmacy chains, and additionally provides nursing care facility operations, home care services, and rental and sales of care products. The group also supplies pharmaceuticals, cosmetics, daily necessities, and other products.

The Administrative Support business handles procurement and sales of products carried by group companies, management oversight and coordination, and outsourced administrative functions. Additionally, it engages in planning and development of private brand products, asset management and operations, store construction and maintenance, staffing and placement services, and sales agency services for life insurance and property insurance.

Management Policy

Matsukiyo Cocokara & Company is pursuing a unique growth strategy aimed at sustainable expansion. The company targets becoming Asia's No. 1 drugstore and establishing a leading position in the beauty and health sectors. To achieve this goal, the company prioritizes organic growth while working to improve sales, EBITDA margins, and ROE.

Under its medium-term management plan through March 2031, the company has identified three key strategies. First, it aims to strengthen seamless collaboration between its drugstore and pharmacy operations to enhance customer convenience. Second, it is advancing operational efficiency through digital technology and expanding its business domains. Third, it is accelerating store openings primarily in major metropolitan areas and pursuing M&A to expand business scale.

To realize sustainable management, Matsukiyo Cocokara & Company is addressing environmental and social responsibilities while strengthening corporate governance. Specifically, the company targets reducing CO2 emissions and increasing the proportion of environmentally conscious products. Additionally, it is creating a more employee-friendly workplace and developing professional talent.

Under its cash allocation policy, the company allocates 45% each to growth investments and shareholder returns, with the remaining 10% directed to strengthening its financial foundation. For growth investments, priority is given to new store openings, renovations, mid-sized M&A, and overseas business investments. For shareholder returns, the company adopts progressive dividends as its basic approach, targeting a dividend payout ratio of 50%.

AI Chat